loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 19488 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NICARDIPINE HYDROCHLORIDE (2)

filter

01 CHIESI (2)

filter

01 CAPSULE;ORAL (2)

filter

01 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (2)

URL Supplier Web Content
CAPSULE;ORAL
30MG **Federal Registe...
CARDENE
USA
19488
1988-12-21
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE;ORAL
20MG **Federal Registe...
CARDENE
USA
19488
1988-12-21
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 19488

Looking for CTD TGA MCC DOSSIER APPLICATION 19488 2

19

CHIESI USA INC, based in U.S.A, is a pharmaceutical company.

One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 19488 and regulatory information .

proudly manufactured in the

approval since 1988-12-21

CHIESI USA INC's CARDENE CAPSULE;ORAL, medication with 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.

18

CHIESI USA INC, based in U.S.A, is a pharmaceutical company.

One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 19488 and regulatory information .

proudly manufactured in the

approval since 1988-12-21

CHIESI USA INC's CARDENE CAPSULE;ORAL, medication with 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY